Clinical Trial Planning and Management

This contract involves comprehensive clinical trial planning and management services focused on Phase II trials for blood analogs and diagnostic devices. Key responsibilities include developing clinical protocols, selecting appropriate trial sites, managing Institutional Review Board (IRB) submissions, and coordinating overall trial activities to ensure compliance and efficiency throughout the study. The subcontract is issued by the Defense Advanced Research Projects Agency under the Department of Defense and falls under the NAICS code 541612, which relates to administrative management and general management consulting services. The solicitation was posted on May 27, 2026, with a response deadline set for June 24, 2026. Although specific location details for performance are not provided, the contract aims to support advanced clinical research processes essential for the development and validation of innovative blood analogs and diagnostic tools. This opportunity targets experienced organizations capable of navigating complex regulatory requirements and coordinating multi-site clinical trials within a defense-related research context.